https://www.selleckchem.com/pr....oducts/capsazepine.h
We investigated the relationship between glucose variability and frailty. Forty-eight type 2 diabetic patients aged ≥ 65 years were enrolled. The FRAIL scale was used for frailty assessment, and participants were classified into 'healthy pre-frail' (n = 24) and 'frail' (n = 24) groups. A continuous glucose monitoring (CGM) system was used for a mean of 6.9 days and standardized CGM metrics were analyzed mean glucose, glucose management indicator (GMI), coefficient of variation, and time in range, time above range (TAR), and ti